Product Information
IMITREX 6 MG/0.5 ML PEN INJECT is a brand product labeled by GlaxoSmithKline LLC, priced at $462.0033 per ML under NDC 00173047900. Its NADAC has been published 398 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173047900
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080On Market Since
1/23/1997
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 6 MG/0.5 ML PEN INJECT has been published 398 times since Nov 28, 2013, and over the history we have for it it has risen 127.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $462.0033 per ML |
|---|---|
| All-time high | $462.7350 (Jun 11, 2025) |
| All-time low | $203.1120 (Nov 28, 2013) |
| 52-week high | $462.6322 |
| 52-week low | $461.0213 |
| Median price | $355.6500 |
| Average price | $356.2869 |
| Largest weekly change | +19.7% (May 22, 2024) |
| Weeks tracked | 398 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMITREX 6 MG/0.5 ML PEN INJECT?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 6 MG/0.5 ML PEN INJECT, manufactured by GlaxoSmithKline LLC, is $462.0033 per ML (NDC 00173047900), effective Jun 24, 2026.
How has the price of IMITREX 6 MG/0.5 ML PEN INJECT changed over time?
Over the history we have for it, the NADAC for IMITREX 6 MG/0.5 ML PEN INJECT has risen 127.5%. It has been tracked across 398 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 6 MG/0.5 ML PEN INJECT?
Since Nov 28, 2013, the NADAC for IMITREX 6 MG/0.5 ML PEN INJECT has ranged from a low of $203.1120 (Nov 28, 2013) to a high of $462.7350 (Jun 11, 2025), with a median of $355.6500 per ML.
Are there cheaper alternatives to IMITREX 6 MG/0.5 ML PEN INJECT?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $14.9286 per ML — about 97% below IMITREX 6 MG/0.5 ML PEN INJECT.
Who manufactures IMITREX 6 MG/0.5 ML PEN INJECT?
IMITREX 6 MG/0.5 ML PEN INJECT (NDC 00173047900) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification